DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Epicatechin is an investigational drug.
There have been 14 clinical trials for Epicatechin. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2008.
The most common disease conditions in clinical trials are Muscular Dystrophies, Muscular Dystrophy, Duchenne, and Prediabetic State. The leading clinical trial sponsors are Cardero Therapeutics, Inc., National Center for Complementary and Integrative Health (NCCIH), and Craig McDonald, MD.
Recent Clinical Trials for Epicatechin
|Safety and Biomarker Response to (+)-Epicatechin in Becker Muscular Dystrophy||Epirium Bio Inc.||Phase 1|
|Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents||Cardero Therapeutics, Inc.||Phase 1/Phase 2|
|Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents||Craig McDonald, MD||Phase 1/Phase 2|